Using a Mendelian randomization approach to explore a causal relationship between vitamin D and nonmelanoma skin cancer
Br J Dermatol
.
2018 Jun;178(6):1241-1242.
doi: 10.1111/bjd.16599.
Authors
Y Kim
1
2
,
P Kraft
3
,
M M Asgari
1
2
Affiliations
1
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, U.S.A.
2
Department of Dermatology, Massachusetts General Hospital, Boston, MA, U.S.A.
3
Department of Epidemiology and Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, U.S.A.
PMID:
29897124
PMCID:
PMC7721246
DOI:
10.1111/bjd.16599
No abstract available
Publication types
Comment
MeSH terms
Calcifediol
Humans
Random Allocation
Skin Neoplasms*
Vitamin D* / analogs & derivatives
Substances
Vitamin D
25-hydroxyvitamin D
Calcifediol
Grants and funding
K24 AR069760/AR/NIAMS NIH HHS/United States
U01 HG009088/HG/NHGRI NIH HHS/United States